Dri Methadone Metabolite Enzyme Immunoassay
Enzyme Immunoassay, Methadone. 510(k) K023617, from Microgenics Corp. (Fremont Blvd., CA). Product code DJR, class 2.
As of Nov 20, 2026, K023617 is an FDA 510(k) held by Microgenics Corp., substantially equivalent on Aug 27, 2003 after 302 days, with no recalls tied to it in FDA's recall database.
- Review time: 302 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The Methadone Metabolite Immunoassay is intended to be used for the qualitative and semi-quantitative determination of the presence of Methadone Metabolite (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine or EDDP) in human urine at cutoffs of 300 and 1000 ng/mL. The semi-quantitative range of the assay is 31-2000 ng/mL.
- Methadone Metabolite Eia AssayK931780 · Diagnostic Reagents, Inc. · Aug 23, 1993
- Immunalysis EDDP Specific Urine Enzyme Immunoassay, Immunalysis EDDP Urine Calibrators, Immunalysis EDDP Urine Control…K151395 · Immunalysis Corporation · Jul 24, 2015
- One Step Eddp (Methadone Metabolite) Test StripK092048 · Biosite Incorporated · Apr 19, 2010
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 29, 2002
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3620
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files